Collaboration at a Glance

 

Primary Focus

Global education and Collaboration for Wilms tumor

 

Supports​

Children, Families, Healthcare Professionals, Researchers, Governments

 

Flagship Programme

Global Wilms Tumor Initiative™

 

Key Initiatives

International webinar series, Educational Literature, WilmsTumor WebApp™, Wilms Tumor Knowledge Index™, Digital Education

 

Strategic Alignment

WHO (Global Initiative for Childhood Cancer), global health equity, pediatric oncology education

 

Geographic Reach

Global with emphasis on underserved and resource-limited regions)

​​​

 

About St. Jude Children's Research Hospital

​

Founded in 1962 by entertainer Danny Thomas, St. Jude Children's Research Hospital has become one of the world's leading centres for childhood cancer treatment, research, education, and global capacity building. Based in Memphis, Tennessee, USA, St. Jude is internationally recognised for advancing scientific discovery, developing innovative treatment approaches, sharing knowledge with healthcare professionals around the world, and helping improve survival rates for children diagnosed with cancer and other life-threatening diseases.

​

One of St. Jude's defining principles is that families should never receive a bill for treatment, travel, housing, or food from St. Jude. This commitment has enabled the hospital to focus entirely on delivering world-class patient care while simultaneously investing in research that benefits children far beyond its own campus. Discoveries made at St. Jude have helped shape treatment protocols used internationally and have contributed significantly to improvements in childhood cancer survival over recent decades.

​

Beyond its clinical and research programmes, St. Jude plays an increasingly important role in global childhood cancer through international education, healthcare professional training, collaborative research, implementation science, knowledge exchange, and support for countries working to strengthen childhood cancer services. These activities closely align with international efforts to reduce inequalities in childhood cancer care and improve access to evidence-based treatment worldwide.

​

For children diagnosed with Wilms tumor, St. Jude's expertise extends across many areas of care, including diagnosis, imaging, pathology, surgery, chemotherapy, radiation therapy, supportive care, survivorship, late effects, clinical research, and long-term follow-up. The institution's multidisciplinary approach and commitment to global knowledge sharing have helped establish it as one of the world's most respected leaders in pediatric oncology.

​

Website: https://www.stjude.org/

​

The Global Impact of St. Jude Children's Research Hospital

 

For more than six decades, St. Jude Children's Research Hospital has helped shape the landscape of pediatric oncology through scientific discovery, clinical excellence, education, and international collaboration. While best known for the care it provides to children treated at its Memphis campus, the institution's influence extends far beyond the United States through research publications, clinical protocols, educational initiatives, professional training programmes, and global health partnerships.

Today, healthcare professionals around the world benefit from knowledge generated through St. Jude's work. Research findings contribute to improvements in diagnosis, treatment planning, supportive care, survivorship, and long-term follow-up for children with cancer, while educational programmes help strengthen healthcare systems by supporting clinicians in countries with varying levels of specialist expertise and resources.

​

For children diagnosed with Wilms tumor, this global impact is particularly significant. Although treatment outcomes have improved dramatically in many parts of the world, major disparities remain between countries. Children living in low- and middle-income countries are still more likely to experience delayed diagnosis, limited access to specialist care, interruptions to treatment, and poorer long-term outcomes.

​

Reducing these inequalities requires international leadership, collaboration, and a willingness to share knowledge across borders. Institutions such as St. Jude play an important role in this process by supporting education, encouraging scientific collaboration, and helping healthcare professionals apply evidence-based practice within their own healthcare systems. Through its collaboration with St. Jude, the Wilms Cancer Foundation seeks to complement these broader efforts by ensuring that families, clinicians, researchers, and patient advocates also have access to trusted educational resources dedicated specifically to Wilms tumor.

​

The collaboration therefore reflects a shared commitment to ensuring that advances in childhood cancer benefit children everywhere—not only those treated at major specialist centres, but also those receiving care in regional hospitals and resource-limited settings across the world.

​

Why St. Jude Matters for Wilms Tumor

​

Although Wilms tumor (nephroblastoma) is considered a rare childhood cancer, it remains the most common kidney cancer affecting children worldwide. Survival rates have improved significantly in many high-income countries due to advances in surgery, chemotherapy, radiation therapy, supportive care, multidisciplinary treatment planning, and international clinical research. However, substantial disparities remain between countries, with many children in low- and middle-income settings continuing to face delayed diagnosis, limited access to specialist care, treatment abandonment, and poorer outcomes.

Addressing these challenges requires more than clinical expertise alone. It requires international collaboration, healthcare professional education, evidence-based clinical guidance, family support, knowledge translation, and sustained efforts to strengthen healthcare systems. These priorities closely reflect St. Jude's international mission and are central to the objectives of the World Health Organization's Global Initiative for Childhood Cancer (GICC), which seeks to improve survival and quality of life for children with cancer worldwide.

​

The collaboration between St. Jude Children's Research Hospital and the Wilms Cancer Foundation recognises that improving outcomes for children with Wilms tumor depends upon sharing knowledge across borders, empowering healthcare professionals with trusted educational resources, supporting parents and caregivers throughout the treatment journey, and encouraging earlier recognition of childhood kidney cancer. By combining specialist expertise with global educational initiatives, both organisations contribute to a broader international movement focused on reducing disparities in care and improving long-term outcomes for children affected by Wilms tumor.

​

The partnership also supports the growing recognition that education is one of the most powerful tools available for improving childhood cancer outcomes. When families, clinicians, researchers, advocacy organisations, and governments have access to high-quality, evidence-based information, opportunities increase for earlier diagnosis, more effective treatment, improved survivorship, and stronger international cooperation.

​

Supporting the Global Wilms Tumor Initiative™

​

The collaboration with St. Jude Children's Research Hospital represents an important milestone in the continued international expansion of the Global Wilms Tumor Initiative™ (GWTI), the Wilms Cancer Foundation's flagship programme dedicated to improving outcomes for children diagnosed with Wilms tumor through education, advocacy, awareness, healthcare professional engagement, digital innovation, and international collaboration.

​

The Global Wilms Tumor Initiative™ is built upon the principle that meaningful improvements in childhood kidney cancer care can only be achieved through coordinated international partnerships. By working alongside internationally recognised organisations, healthcare institutions, patient advocacy groups, researchers, clinicians, and policymakers, the Initiative seeks to strengthen the global response to Wilms tumor while helping reduce inequalities in diagnosis, treatment, survivorship, and access to trusted information.

​

Collaboration with St. Jude strengthens this vision by combining the Foundation's specialist expertise in Wilms tumor with one of the world's leading institutions for childhood cancer research, education, and global health. Together, both organisations aim to support healthcare professionals through evidence-based educational initiatives, expand access to trusted information for children and families, encourage international knowledge sharing, and contribute to improvements in childhood cancer care across diverse healthcare settings.

​

The collaboration also complements the Foundation's wider portfolio of international programmes, including the Wilms Tumor Knowledge Index™ (WTKI), the Wilms Tumor WebApp, multilingual educational resources, healthcare professional learning materials, international webinar programmes, and future digital initiatives designed to improve awareness, support earlier diagnosis, strengthen survivorship, and promote equitable access to evidence-based information around the world.

​

Rather than representing a single project, the collaboration forms part of a broader long-term strategy to build a globally connected network of organisations working together to improve outcomes for every child diagnosed with Wilms tumor. Through the Global Wilms Tumor Initiative™, the Wilms Cancer Foundation continues to bring together expertise from leading international institutions to accelerate education, strengthen collaboration, and help ensure that no child is disadvantaged by where they live or the resources available within their healthcare system.

​​

Why This Collaboration Matters

 

The collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital extends beyond the relationship between two organisations. It represents a shared commitment to strengthening the global ecosystem that supports children with Wilms tumor through education, evidence, and international cooperation.

​

As the Global Wilms Tumor Initiative™ continues to expand, partnerships with internationally respected institutions help ensure that the Foundation's educational resources remain aligned with current scientific understanding, recognised standards of pediatric oncology, and the evolving needs of families and healthcare professionals. At the same time, the Foundation contributes its specialist focus on Wilms tumor, childhood kidney cancer, patient education, and global advocacy, helping ensure that this rare disease receives the dedicated attention it deserves.

​

Together, the collaboration demonstrates how organisations with different but complementary strengths can work towards a common goal: improving outcomes and quality of life for every child diagnosed with Wilms tumor. By promoting education, encouraging knowledge sharing, supporting healthcare professionals, and empowering families, the partnership contributes to a broader international effort to reduce disparities in care and create a future in which children everywhere have the opportunity to benefit from the best available knowledge and expertise.

​​

​

​

Strengthening International Collaboration

 

The collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital forms part of a broader international strategy to strengthen cooperation between leading organisations working to improve outcomes for children diagnosed with Wilms tumor and other childhood cancers.

​

Childhood cancer presents global challenges that extend well beyond medical treatment alone. Differences in healthcare infrastructure, specialist workforce capacity, diagnostic services, access to medicines, survivorship programmes, and educational resources continue to influence outcomes for children around the world. Addressing these challenges requires sustained collaboration between hospitals, researchers, healthcare professionals, governments, patient advocacy organisations, and international health agencies.

​

Through the Global Wilms Tumor Initiative™, the Wilms Cancer Foundation is building an international network of organisations committed to improving awareness, accelerating earlier diagnosis, strengthening education, supporting healthcare professionals, and promoting equitable access to evidence-based information. The collaboration with St. Jude represents an important component of this wider programme by bringing together specialist expertise in Wilms tumor with one of the world's leading institutions in childhood cancer research, education, and global capacity building.

​

The collaboration also complements the Foundation's wider programme of international engagement, including its collaboration with the World Health Organization (WHO) in support of the Global Initiative for Childhood Cancer (GICC), membership of Childhood Cancer International (CCI) and the International Kidney Cancer Coalition (IKCC), engagement with the International Society of Paediatric Oncology (SIOP), and strategic partnerships with organisations such as MAHAK in Iran. Together, these relationships strengthen the Foundation's ability to deliver internationally relevant education, support healthcare professionals, and improve outcomes for children diagnosed with Wilms tumor across diverse healthcare settings.

​

By sharing expertise, encouraging innovation, and promoting international knowledge exchange, the collaboration contributes to a growing global movement focused on reducing inequalities in childhood cancer care while helping every child benefit from advances in diagnosis, treatment, survivorship, and long-term follow-up.

​

Supporting Children and Families Worldwide

 

Every year, thousands of families around the world begin an unexpected journey following a diagnosis of Wilms tumor. For many parents and caregivers, the diagnosis introduces unfamiliar medical terminology, complex treatment decisions, emotional uncertainty, and concerns about their child's future. Access to accurate, evidence-based information and compassionate support can make a profound difference throughout this journey.

​

The collaboration between the Wilms Cancer Foundation and St. Jude seeks to strengthen the educational resources available to families by supporting the development and dissemination of trusted information covering every stage of the Wilms tumor journey. From recognising early symptoms and understanding diagnostic investigations to learning about surgery, chemotherapy, radiation therapy, survivorship, and long-term follow-up care, the collaboration aims to make high-quality educational material more accessible to families around the world.

​

The partnership also supports the Foundation's commitment to expanding multilingual educational resources so that more parents and caregivers can access reliable information in their own language. By combining specialist expertise with internationally recognised educational approaches, the collaboration contributes to improving health literacy, empowering families to participate confidently in their child's care, and helping reduce anxiety during what is often one of the most challenging periods of their lives.

​

Beyond education, the collaboration reflects a shared belief that every child deserves equitable access to knowledge, support, and hope, regardless of where they live or the resources available within their healthcare system.

​

Supporting Healthcare Professionals

 

Healthcare professionals remain central to improving outcomes for children diagnosed with Wilms tumor. Advances in survival over recent decades have been achieved through multidisciplinary care involving pediatric oncologists, pediatric surgeons, nephrologists, radiologists, radiation oncologists, pathologists, specialist nurses, pharmacists, psychologists, rehabilitation teams, and many other healthcare professionals working together to deliver coordinated, evidence-based treatment.

​

The collaboration between the Wilms Cancer Foundation and St. Jude aims to support healthcare professionals by expanding access to trusted educational resources, encouraging international knowledge exchange, and promoting the dissemination of current evidence and best practice. Through initiatives such as the proposed international webinar series, educational literature, digital learning resources, and professional engagement activities, the collaboration seeks to complement existing educational opportunities while helping clinicians remain informed about developments in Wilms tumor diagnosis, treatment, survivorship, and long-term care.

​

Particular emphasis is placed on supporting healthcare professionals working in low- and middle-income countries, where access to specialist education and international professional networks may be more limited. By encouraging collaboration across healthcare systems and sharing internationally recognised educational resources, the partnership aims to contribute to stronger clinical capacity and improved patient care worldwide.

​

The Foundation believes that empowering healthcare professionals through education ultimately benefits every child diagnosed with Wilms tumor by promoting earlier diagnosis, informed clinical decision-making, multidisciplinary collaboration, and consistent application of evidence-based care.

​

Supporting Researchers

 

Scientific research continues to transform the outlook for children diagnosed with Wilms tumor. Advances in molecular biology, genetics, precision medicine, imaging, surgery, chemotherapy, radiation therapy, survivorship, and supportive care have all contributed to substantial improvements in survival and quality of life. Continued progress depends upon collaboration between researchers, clinicians, healthcare institutions, and patient organisations committed to translating scientific discoveries into meaningful improvements in patient care.

​

The collaboration between the Wilms Cancer Foundation and St. Jude supports this broader culture of international knowledge sharing by encouraging dialogue between researchers, facilitating the dissemination of educational resources, and promoting greater awareness of developments within pediatric renal oncology.

​

While the Foundation does not position itself as a primary research institution, it plays an important role in knowledge translation—helping ensure that research findings become understandable and accessible for healthcare professionals, families, advocacy organisations, policymakers, and the wider public. Through initiatives such as the Wilms Tumor Knowledge Index™, the Foundation seeks to bridge the gap between scientific evidence and practical application, supporting informed decision-making and encouraging wider adoption of evidence-based practice.

​

The collaboration therefore contributes not only to scientific awareness but also to the broader goal of ensuring that advances in childhood cancer research ultimately benefit children and families around the world.

​

Supporting Governments and Health Systems

 

Governments, public health authorities, and healthcare systems play a critical role in improving childhood cancer outcomes. Sustainable progress requires investment in healthcare infrastructure, workforce development, early diagnosis programmes, access to essential medicines, multidisciplinary treatment services, survivorship care, and ongoing professional education.

​

The collaboration between the Wilms Cancer Foundation and St. Jude supports these wider objectives by promoting internationally recognised educational resources and encouraging cooperation between organisations working to strengthen childhood cancer services globally. These efforts align closely with the objectives of the World Health Organization's Global Initiative for Childhood Cancer (GICC), which seeks to improve survival while reducing inequalities in childhood cancer care through stronger health systems and increased access to quality treatment.

​

Through the Global Wilms Tumor Initiative™, the Foundation aims to complement these international efforts by providing educational resources, supporting healthcare professionals, facilitating international collaboration, and promoting greater awareness of Wilms tumor among policymakers and healthcare leaders. By strengthening knowledge and encouraging cooperation across countries and healthcare systems, the collaboration contributes to long-term improvements that extend well beyond individual institutions.

​

Ultimately, improving outcomes for children with Wilms tumor requires a coordinated global response. By working alongside internationally recognised organisations such as St. Jude Children's Research Hospital, the Wilms Cancer Foundation continues to support a future in which every child—regardless of geography or circumstance—has access to timely diagnosis, evidence-based treatment, informed healthcare professionals, and the opportunity to survive and thrive.

​​

Advancing Global Education for Wilms Tumor

 

Education remains one of the most effective and sustainable ways of improving outcomes for children diagnosed with Wilms tumor. Earlier recognition of symptoms, timely referral for specialist assessment, evidence-based treatment, effective survivorship care, and informed family participation all depend upon access to reliable knowledge.

For this reason, education sits at the centre of the collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital.

​

Through the Global Wilms Tumor Initiative™, the Foundation is building one of the world's most comprehensive educational programmes dedicated exclusively to childhood kidney cancer. This includes evidence-based literature, multilingual resources, digital education, healthcare professional learning materials, the Wilms Tumor Knowledge Index™, the Wilms Tumor WebApp, and the proposed international webinar series.

​

Working alongside internationally respected organisations strengthens this vision by encouraging the exchange of expertise, supporting educational innovation, and helping ensure that resources reflect recognised standards of pediatric oncology. As educational programmes continue to evolve, the collaboration aims to make high-quality information increasingly accessible to children, families, healthcare professionals, students, researchers, advocacy organisations, and policymakers.

Education also plays an important role in reducing global inequalities. In many regions, access to specialist pediatric oncology expertise may be limited, while opportunities for continuing professional education can vary considerably. Digital learning, multilingual educational resources, and international knowledge sharing help bridge these gaps by making trusted information available regardless of geography.

​

By investing in education today, the collaboration contributes to better-informed healthcare professionals, more confident families, stronger healthcare systems, and ultimately improved outcomes for future generations of children diagnosed with Wilms tumor.

​​

​

​​​

Areas of Collaboration

 

The collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital has been established around a shared commitment to improving outcomes for children diagnosed with Wilms tumor through education, international collaboration, healthcare professional engagement, and knowledge sharing.

​

Rather than focusing on a single project, the collaboration supports a broad programme of activities designed to strengthen awareness, improve access to evidence-based educational resources, encourage international cooperation, and support children, families, healthcare professionals, researchers, and policymakers. Together, these activities contribute to the continued international expansion of the Global Wilms Tumor Initiative™, helping build a globally connected community committed to improving childhood kidney cancer care.

​​

International Webinar Series

 

One of the principal areas of collaboration is the development of an international educational webinar series dedicated exclusively to Wilms tumor and childhood kidney cancer.

​

The proposed programme is intended to bring together leading international experts, clinicians, researchers, allied health professionals, survivors, and patient advocates to deliver evidence-based educational sessions covering every stage of the Wilms tumor journey. Planned topics include early recognition of symptoms, diagnostic pathways, staging, surgery, chemotherapy, radiation therapy, relapse, survivorship, long-term follow-up care, nutrition, psychosocial support, and emerging developments in pediatric renal oncology.

​

The webinar series aims to provide accessible education for multiple audiences, including parents and caregivers seeking reliable information, healthcare professionals wishing to expand their knowledge, students entering pediatric oncology, and clinicians working in regions where access to specialist education may be limited. By making internationally recognised expertise more widely available, the collaboration seeks to strengthen knowledge sharing and support improvements in clinical practice across diverse healthcare settings.

​

Educational Literature and Knowledge Translation

 

The collaboration also supports the development of comprehensive educational literature designed to improve understanding of Wilms tumor among families, healthcare professionals, students, researchers, and policymakers.

​

Building upon the Foundation's growing library of evidence-based publications, the collaboration aims to produce educational resources that explain complex medical concepts using clear, accessible language while remaining scientifically accurate. These materials are intended to support every stage of the patient journey, from recognising early symptoms and understanding diagnostic investigations through treatment, survivorship, long-term follow-up, and life beyond cancer.

​

A central objective of this work is knowledge translation—ensuring that advances in research and clinical practice become understandable and practical for those directly affected by childhood kidney cancer. By transforming scientific evidence into educational resources that can be used in clinical settings, schools, community organisations, and homes around the world, the collaboration seeks to improve health literacy while supporting informed decision-making for families and healthcare professionals alike.

​

Digital Education and the Wilms Tumor WebApp

 

Digital innovation represents an increasingly important component of the Global Wilms Tumor Initiative™. The collaboration supports the Foundation's vision of expanding access to trusted educational resources through modern digital technologies capable of reaching families and healthcare professionals regardless of geographic location.

The Wilms Tumor WebApp forms a key element of this strategy by bringing together evidence-based information covering symptoms, diagnosis, staging, treatment, survivorship, nutrition, long-term follow-up care, global treatment centres, patient resources, and educational literature within a single, accessible digital platform.

​

As the collaboration develops, opportunities exist to further strengthen the educational content available through the WebApp by supporting internationally informed resources that reflect current evidence and recognised standards of care. In doing so, the partnership contributes to improving access to reliable information while helping reduce disparities in educational resources between countries.

​

The Wilms Tumor Knowledge Index™

 

The Wilms Tumor Knowledge Index™ (WTKI) has been developed by the Wilms Cancer Foundation as a comprehensive knowledge hub dedicated exclusively to Wilms tumor and childhood kidney cancer.

​

The collaboration with St. Jude complements this initiative by supporting the Foundation's commitment to organising, expanding, and communicating evidence-based information for a global audience. Through the continued development of the Knowledge Index™, healthcare professionals, researchers, students, families, and advocacy organisations will have access to an increasingly comprehensive library of educational content covering every aspect of Wilms tumor.

​

By combining specialist expertise with internationally recognised educational principles, the collaboration contributes to creating one of the world's most comprehensive online resources dedicated to childhood kidney cancer.

​

Healthcare Professional Education

 

Supporting healthcare professionals remains one of the most important objectives of the collaboration.

​

Doctors, nurses, surgeons, nephrologists, radiologists, radiation oncologists, pathologists, pharmacists, psychologists, rehabilitation specialists, and allied health professionals all play essential roles throughout the diagnosis, treatment, and long-term care of children diagnosed with Wilms tumor. Ensuring these professionals have access to current evidence, educational resources, and international expertise contributes directly to improving patient outcomes.

​

Through educational literature, digital learning resources, webinars, conference participation, and future collaborative initiatives, the partnership aims to complement existing professional education while encouraging international dialogue and the sharing of best practice across healthcare systems.

​

Conference Participation and International Knowledge Exchange

 

International scientific meetings and professional conferences provide valuable opportunities for healthcare professionals, researchers, patient organisations, and policymakers to exchange knowledge, discuss emerging evidence, and strengthen collaborative relationships.

​

The collaboration supports participation in appropriate international meetings where opportunities exist to share educational initiatives, discuss developments in Wilms tumor care, promote evidence-based resources, and encourage dialogue surrounding childhood kidney cancer. These activities also contribute to the broader objectives of the Global Wilms Tumor Initiative™ by strengthening international networks and supporting multidisciplinary cooperation.

​

By participating in conferences alongside organisations such as the World Health Organization (WHO), the International Society of Paediatric Oncology (SIOP), Childhood Cancer International (CCI), the International Kidney Cancer Coalition (IKCC), and other international partners where appropriate, the Foundation continues building meaningful relationships that support children with Wilms tumor worldwide.

​

Global Awareness and Public Education

 

Earlier diagnosis remains one of the most effective ways of improving outcomes for children diagnosed with Wilms tumor. Increasing awareness among parents, caregivers, healthcare professionals, educators, and communities can help reduce delays in recognising symptoms and accessing specialist care.

​

The collaboration therefore supports the development of international awareness initiatives designed to improve understanding of childhood kidney cancer while encouraging earlier recognition of symptoms and timely referral for specialist assessment.

​

These awareness activities complement the Foundation's wider educational programme and seek to ensure that families receive reliable, evidence-based information rather than misinformation or outdated resources. Through coordinated public education, multilingual communication, and digital engagement, the collaboration contributes to improving awareness of Wilms tumor on a global scale.

​​

​

​

​

Looking Towards the Future

 

The collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital has been established with a long-term vision of strengthening international education, supporting healthcare professionals, empowering families, and improving outcomes for children diagnosed with Wilms tumor.

​

As the Global Wilms Tumor Initiative™ continues to expand, opportunities exist to further develop educational programmes, digital learning resources, international webinar series, healthcare professional engagement, multilingual educational literature, conference participation, and future collaborative initiatives that strengthen the global response to childhood kidney cancer.

​

Rather than representing a single programme, the collaboration forms part of a broader international strategy to build a connected network of organisations committed to improving awareness, education, survivorship, health equity, and access to evidence-based care. Through continued partnership and shared expertise, the Wilms Cancer Foundation and St. Jude Children's Research Hospital seek to contribute to a future in which every child diagnosed with Wilms tumor benefits from the very best that international collaboration can offer.

​​​​

Supporting the World Health Organization's Global Initiative for Childhood Cancer

 

The objectives of the collaboration closely complement the ambitions of the World Health Organization's Global Initiative for Childhood Cancer (GICC), which seeks to improve survival and quality of life for children with cancer while reducing inequalities in access to diagnosis, treatment, and supportive care.

​

Although the collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital is independent of the WHO, many of its educational priorities align with the broader goals promoted through the Global Initiative for Childhood Cancer. These include strengthening healthcare professional education, encouraging earlier diagnosis, supporting multidisciplinary care, expanding access to evidence-based information, promoting survivorship, and encouraging international cooperation between organisations working to improve childhood cancer outcomes.

​

The Wilms Cancer Foundation's own collaboration with the World Health Organization, together with its support for the Global Initiative for Childhood Cancer, provides an important framework within which partnerships such as St. Jude can contribute complementary expertise. By connecting specialist Wilms tumor education with internationally recognised leadership in pediatric oncology, the collaboration helps reinforce a global movement dedicated to improving childhood cancer care.

​

This alignment also reflects the Foundation's commitment to ensuring that its programmes support internationally recognised priorities while remaining focused on the unique needs of children diagnosed with Wilms tumor. Through education, advocacy, digital innovation, and international collaboration, the Global Wilms Tumor Initiative™ seeks to complement wider global efforts to strengthen childhood cancer services and improve health equity worldwide.

​​​

Why International Collaboration Matters for Rare Childhood Cancers

 

Rare diseases present unique challenges for patients, families, healthcare professionals, and researchers. Because relatively few children are diagnosed with Wilms tumor each year compared with more common cancers, opportunities to accumulate clinical experience, conduct research, and develop specialist expertise often depend upon collaboration between institutions, countries, and international organisations.

​

No single hospital, charity, university, or healthcare system can address every challenge associated with a rare childhood cancer alone. Progress is achieved when clinicians share experience, researchers collaborate across borders, educational organisations translate scientific evidence into practical guidance, and patient advocacy groups ensure that families remain informed and supported throughout the treatment journey.

​

International collaboration also helps accelerate the adoption of evidence-based practice. As new discoveries emerge in areas such as molecular biology, genetics, precision medicine, imaging, surgery, chemotherapy, radiation therapy, survivorship, and supportive care, collaboration allows this knowledge to be shared more rapidly across healthcare systems. This benefits clinicians by supporting continuing professional education, while helping families gain access to accurate and up-to-date information.

​

For children living in regions where specialist pediatric oncology services may be limited, collaboration becomes even more important. International educational resources, digital technologies, professional networks, and partnerships between organisations can help reduce disparities in knowledge and improve access to trusted information. While education alone cannot overcome every healthcare challenge, it provides an essential foundation upon which stronger healthcare systems and improved patient outcomes can be built.

​

The collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital reflects this philosophy. By combining complementary expertise and contributing to a wider international network of organisations committed to childhood cancer, the partnership supports a future in which knowledge is shared more openly, educational opportunities become more widely available, and children diagnosed with Wilms tumor benefit from advances made anywhere in the world.

​

Relationship with the Wilms Cancer Foundation

 

The collaboration between the Wilms Cancer Foundation and St. Jude Children's Research Hospital represents an important milestone in the continued international expansion of the Global Wilms Tumor Initiative™ (GWTI).

​

While the Wilms Cancer Foundation is dedicated exclusively to Wilms tumor and childhood kidney cancer, St. Jude is internationally recognised for its leadership in childhood cancer research, clinical care, education, and global capacity building. By bringing together these complementary areas of expertise, the collaboration seeks to strengthen awareness, improve access to trusted educational resources, support healthcare professionals, encourage international knowledge sharing, and ultimately improve outcomes for children diagnosed with Wilms tumor around the world.

​

The relationship is founded on a shared commitment to ensuring that children and families have access to accurate, evidence-based information throughout the cancer journey. It also reflects a common belief that education, collaboration, and the exchange of knowledge are essential for reducing inequalities in childhood cancer care and improving long-term survival and quality of life.

​

Through this collaboration, the Foundation continues to expand its international network of leading organisations working together to advance the objectives of the Global Wilms Tumor Initiative™. Alongside collaborations with the World Health Organization (WHO), Childhood Cancer International (CCI), the International Kidney Cancer Coalition (IKCC), the International Society of Paediatric Oncology (SIOP), and regional partners, the relationship with St. Jude strengthens the Foundation's ability to deliver globally relevant educational programmes, healthcare professional resources, and family support initiatives.

​

Rather than representing a single project, the collaboration forms part of a long-term strategy to build a connected international community dedicated to improving the lives of children affected by Wilms tumor through cooperation, education, and shared expertise.

​

A Shared Vision for Children with Wilms Tumor

 

Although each organisation has its own unique mission and areas of expertise, the Wilms Cancer Foundation and St. Jude Children's Research Hospital share a common vision: a future in which every child diagnosed with Wilms tumor has the opportunity to receive timely diagnosis, evidence-based treatment, comprehensive supportive care, and long-term survivorship support, regardless of where they live.

​

Achieving this vision requires more than advances in medicine alone. It requires international cooperation, multidisciplinary collaboration, investment in healthcare professional education, stronger healthcare systems, greater public awareness, and improved access to reliable information for families and caregivers. Through the Global Wilms Tumor Initiative™, the Foundation is committed to helping bring these elements together while working alongside internationally respected organisations that share similar objectives.

​

The collaboration also reflects a broader belief that progress in childhood cancer is accelerated when knowledge is shared openly, educational resources are made widely available, and organisations work collectively rather than independently. By combining specialist expertise in Wilms tumor with internationally recognised leadership in pediatric oncology, the collaboration contributes to a stronger global response to childhood kidney cancer and supports continuing improvements in care for future generations.

​

Looking Ahead

 

The Wilms Cancer Foundation views this collaboration as the beginning of an evolving relationship that has the potential to support children, families, healthcare professionals, researchers, and healthcare systems through a wide range of educational and collaborative initiatives.

​

Future opportunities include the continued development of the proposed international webinar series, expansion of multilingual educational literature, healthcare professional learning resources, digital education through the Wilms Tumor WebApp, further growth of the Wilms Tumor Knowledge Index™, conference participation, and initiatives that strengthen awareness and encourage earlier diagnosis of childhood kidney cancer.

​

The Foundation also remains committed to aligning its international programmes with broader global priorities, including the objectives of the World Health Organization's Global Initiative for Childhood Cancer (GICC). By working alongside internationally recognised organisations such as St. Jude Children's Research Hospital, the Foundation aims to continue expanding the reach and impact of the Global Wilms Tumor Initiative™ while supporting improvements in childhood kidney cancer care across both high-income countries and low- and middle-income settings.

​

As international collaboration continues to evolve, the Foundation believes that partnerships built upon shared expertise, mutual respect, scientific excellence, and a commitment to equitable access to knowledge will play an increasingly important role in improving outcomes for children diagnosed with Wilms tumor worldwide.​

What This Means for Parents & Caregivers

 

For parents and caregivers, this collaboration means greater access to trusted, evidence-based educational resources developed through international cooperation. As new educational programmes, digital resources, and learning opportunities are developed, families will benefit from information that reflects current knowledge and recognised standards of childhood cancer care.

​

The collaboration also reinforces the Foundation's commitment to ensuring that parents are supported throughout every stage of the Wilms tumor journey—from recognising symptoms and understanding diagnosis to treatment, survivorship, and life beyond cancer. By working alongside internationally respected organisations, the Foundation seeks to provide families with confidence that the information they receive is accurate, balanced, and focused on helping them make informed decisions in partnership with their healthcare team.

​

Healthcare Professionals

 

Healthcare professionals benefit from stronger opportunities for international knowledge exchange and access to educational resources that support evidence-based practice. Through collaboration with leading organisations in pediatric oncology, the Foundation aims to complement existing professional education by promoting multidisciplinary learning, encouraging dialogue across healthcare systems, and supporting the dissemination of trusted educational materials.

​

For clinicians working in resource-limited settings, improved access to international educational initiatives may also contribute to strengthening local capacity and supporting earlier diagnosis, consistent treatment approaches, and long-term survivorship care.

​

Researchers

 

For researchers, the collaboration highlights the importance of translating scientific discovery into practical improvements that benefit children and families. While research generates new evidence, international collaboration helps ensure that this knowledge is shared widely and incorporated into education, clinical practice, and public awareness.

​

Through initiatives such as the Wilms Tumor Knowledge Index™, educational literature, and digital learning platforms, the Foundation seeks to complement the research community by helping communicate advances in pediatric renal oncology to healthcare professionals, families, policymakers, and advocacy organisations around the world.

Frequently Asked Questions (FAQs)

​​

About St. Jude Children's Research Hospital & the Wilms Cancer Foundation

​

What is St. Jude Children's Research Hospital?

St. Jude Children's Research Hospital is one of the world's leading pediatric healthcare institutions, internationally recognised for advancing childhood cancer research, clinical care, healthcare professional education, and global capacity building. Its work has helped improve survival rates for children with cancer while supporting healthcare professionals and health systems around the world.

​

Key points include:

​

• World-leading pediatric cancer hospital.

• International leader in childhood cancer research.

• Advances treatment, education, and global health.

• Supports healthcare professionals through education and training.

• Contributes to improved outcomes for children worldwide.

 

Why is St. Jude important for children with Wilms tumor?

Although St. Jude treats many forms of childhood cancer, its expertise in pediatric oncology, multidisciplinary care, clinical research, and global education makes it an important contributor to improving care for children diagnosed with Wilms tumor. Through international collaboration and knowledge sharing, its work helps strengthen education and clinical practice worldwide.

​

Key points include:

​

• Expertise in pediatric oncology.

• Supports multidisciplinary treatment.

• Advances childhood cancer research.

• Promotes international education and collaboration.

• Helps improve care for children with Wilms tumor.

 

What is the relationship between the Wilms Cancer Foundation and St. Jude?

The Wilms Cancer Foundation and St. Jude Children's Research Hospital are collaborating to strengthen education, international knowledge sharing, healthcare professional engagement, and awareness of Wilms tumor. The collaboration supports the Foundation's wider Global Wilms Tumor Initiative™ while helping expand access to trusted educational resources for families and clinicians.

​

Key areas of collaboration include:

​

• International education.

• Healthcare professional engagement.

• Educational literature.

• International webinar programmes.

• Digital learning resources.

• Global awareness initiatives.

 

What is the Global Wilms Tumor Initiative™?

The Global Wilms Tumor Initiative™ (GWTI) is the Wilms Cancer Foundation's flagship international programme designed to improve outcomes for children diagnosed with Wilms tumor through education, awareness, advocacy, international collaboration, and digital innovation.

​

The Initiative focuses on:

​

• Early diagnosis and awareness.

• Family education and support.

• Healthcare professional education.

• International collaboration.

• Digital health resources.

• Global health equity.

• Long-term survivorship.

 

How does this collaboration benefit parents and caregivers?

Parents benefit from greater access to trusted, evidence-based educational information developed through international collaboration. The partnership supports resources that help families understand every stage of the Wilms tumor journey while encouraging informed discussions with their healthcare team.

​

Parents can access information about:

​

• Early symptoms.

• Diagnosis and staging.

• Surgery and treatment.

• Chemotherapy and radiation therapy.

• Nutrition and supportive care.

• Survivorship and long-term follow-up.

• Emotional wellbeing and family support.

 

How does the collaboration support healthcare professionals?

Healthcare professionals benefit from educational initiatives designed to encourage international knowledge exchange and promote evidence-based practice. The collaboration seeks to complement existing professional development opportunities through educational resources and international engagement.

 

Areas of support include:

​

• Clinical education.

• International webinar series.

• Educational literature.

• Best practice guidance.

• Knowledge sharing.

• Multidisciplinary collaboration.

• Continuing professional development.

 

Does this collaboration support researchers?

Yes. While the Wilms Cancer Foundation is not a primary research institution, the collaboration supports knowledge translation by helping communicate research findings to healthcare professionals, families, policymakers, and advocacy organisations in an accessible and practical way.

 

This includes:

​

• Research communication.

• Knowledge translation.

• Educational resources.

• International collaboration.

• Evidence dissemination.

• Public understanding of pediatric oncology.

 

How does this collaboration support low- and middle-income countries?

Reducing global inequalities in childhood cancer care is an important objective of the Global Wilms Tumor Initiative™. Through education, multilingual resources, digital learning, and international collaboration, the partnership aims to improve access to trusted information for healthcare professionals and families in resource-limited settings.

​

Potential areas of impact include:

​

• Earlier diagnosis.

• Healthcare professional education.

• Family support.

• Digital access to information.

• Multilingual educational resources.

• International collaboration.

• Health system strengthening.

 

Does the collaboration support the World Health Organization's objectives?

The Wilms Cancer Foundation's wider international strategy aligns with the goals of the WHO Global Initiative for Childhood Cancer by supporting education, awareness, healthcare professional development, and international collaboration. The collaboration with St. Jude complements these broader global efforts through shared educational objectives.

​

Shared priorities include:

​

• Improving childhood cancer outcomes.

• Supporting healthcare professionals.

• Strengthening education.

• Expanding access to reliable information.

• Encouraging international collaboration.

• Promoting health equity.

 

Where can I learn more about Wilms tumor?

The Wilms Cancer Foundation provides one of the world's most comprehensive collections of educational resources dedicated exclusively to Wilms tumor and childhood kidney cancer. Families, healthcare professionals, researchers, and students can explore information covering every stage of the patient journey.

 

Popular resources include:

​

• Symptoms of Wilms tumor.

• Diagnosis and staging.

• Treatment options.

• Surgery and chemotherapy.

• Radiation therapy.

• Relapsed Wilms tumor.

• Survivorship and long-term care.

• Nutrition during treatment.

• Global treatment centres.

• International partnerships.

• Educational literature.

• The Wilms Tumor WebApp.